Fig. 8

hMSCs intervention facilitates the reprogramming of N2 type neutrophils through the PPAR-γ/STAT6/SOCS1 signaling pathway. A: qPCR to detect the expression levels of NE and MPO after hMSC-L treatment. B: qPCR to detect the expression levels of TGF-β and IL-10 after hMSC-L treatment. C: qPCR to detect the expression levels of NE and MPO after hMSC-M treatment. D: qPCR to detect the expression levels of TGF-β and IL-10 after hMSC-M treatment. E: ELISA to detect the expression levels of TGF-β and IL-10 after hMSC-L treatment. F: ELISA to detect the expression levels of TGF-β and IL-10 after hMSC-M treatment. n = 4, versus control ^*P < 0.05, **P < 0.01, ***P < 0.001. versus PMA ^#P < 0.05, ^##P < 0.01, ^###P < 0.001. versus hMSC-L/M ^$P < 0.01, ^$$P < 0.01, ^$$$P < 0.001